ArticleOncoTargets and therapy2018

Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4.

Ting Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.